Polymorphisms in the gene encoding lipoprotein lipase in men with low HDL-C and coronary heart disease

Polymorphisms in the gene encoding lipoprotein lipase in men with low HDL-C and coronary heart disease

Our goal was to further define the role of LPL gene polymorphisms in coronary heart disease (CHD) risk. We determined the frequencies of three LPL polymorphisms (D9N, N291S, and S447X) in 899 men from the Veterans Affairs HDL Intervention Trial (VA-HIT), a study that examined the potential benefits...

Full description

Bibliographic Details
Main Authors:	Margaret E. Brousseau, Allison L. Goldkamp, Dorothea Collins, Serkalem Demissie, Allison C. Connolly, L. Adrienne Cupples, Jose M. Ordovas, Hanna E. Bloomfield, Sander J. Robins, Ernst J. Schaefer
Format:	Article
Language:	English
Published:	Elsevier 2004-10-01
Series:	Journal of Lipid Research
Subjects:	fibrate genetics high density lipoprotein cholesterol lipids
Online Access:	http://www.sciencedirect.com/science/article/pii/S0022227520312621

Similar Items

Ciprofibrate therapy in patients with hypertriglyceridemia and low high density lipoprotein (HDL)-cholesterol: greater reduction of non-HDL cholesterol in subjects with excess body weight (The CIPROAMLAT study)
by: Medel Octavio, et al.
Published: (2004-07-01)

Atorvastatin and Fenofibrate Increase the Content of Unsaturated Acyl Chains in HDL and Modify In Vivo Kinetics of HDL-Cholesteryl Esters in New Zealand White Rabbits
by: Cristóbal Flores-Castillo, et al.
Published: (2019-05-01)

Common genetic variation in multiple metabolic pathways influences susceptibility to low HDL-cholesterol and coronary heart disease[S]
by: Gina M. Peloso, et al.
Published: (2010-12-01)

Influence of HDL-cholesterol-elevating drugs on the in vitro activity of the HDL receptor SR-BI
by: Thomas J.F. Nieland, et al.
Published: (2007-08-01)

Clifford Fibrations and Possible Kinematics
by: Alan S. McRae
Published: (2009-07-01)

Chemical degradation kinetics of fibrates: bezafibrate, ciprofibrate and fenofibrate
by: Marcelo Antonio de Oliveira, et al.

Fibrane the reduced derivative of fenofibrate
by: Amanda E. Kotheimer, et al.
Published: (2020-01-01)

Treating patients with low high-density lipoprotein cholesterol: choices, issues and opportunities
by: Watts Gerald F
Published: (2001-05-01)

The usefulness of information on HDL-cholesterol: potential pitfalls of conventional assumptions
by: Furberg Curt D
Published: (2001-05-01)

Elevando el colesterol HDL: ¿Cuál es la mejor estrategia? Raising HDL cholesterol: which is the best strategy?
by: John Edwin Feliciano Alfonso, et al.
Published: (2008-08-01)

Low incidence of paradoxical reductions in HDL-C levels in dyslipidemic patients treated with fenofibrate alone or in combination with ezetimibe or ezetimibe/simvastatin
by: Farnier Michel, et al.
Published: (2011-11-01)

Combined statin-fibrate therapy-induced rhabdomyolysis: Case report
by: Jozić Tanja L., et al.
Published: (2014-01-01)

Fenofibrate increases HDL-cholesterol by reducing cholesteryl ester transfer protein expression
by: Caroline C. van der Hoogt, et al.
Published: (2007-08-01)

Effet des fibrates sur la synthèse périphérique et le métabolisme hépatique de la bilirubine, un endobiotique aux propriétés anti-oxydantes et athéro-protectrice
by: El Husseini, Diala
Published: (2009)

Isolated low high density lipoprotein-cholesterol (HDL-C): implications of global risk reduction. Case report and systematic scientific review
by: Tyagi Suresh C, et al.
Published: (2005-01-01)

A homologia de uma fibração
by: Pagotto, Pablo Gonzalez [UNESP]
Published: (2016)

Lipid management in the prevention of stroke: a meta-analysis of fibrates for stroke prevention
by: Zhou Yu-Hao, et al.
Published: (2013-01-01)

Fibrations de Lefschetz Réelles
by: Salepci, Nermin
Published: (2007)

A novel compound that elevates high density lipoprotein and activates the peroxisome proliferator activated receptor
by: Charles L. Bisgaier, et al.
Published: (1998-01-01)

VAP II analysis of lipoprotein subclasses in mixed hyperlipidemic patients on treatment with ezetimibe/simvastatin and fenofibrate
by: Michel Farnier, et al.
Published: (2008-12-01)

Problème de centre tangentiel et problème de monodromie pour certains Hamiltoniens non-génériques
by: Pontigo Herrera, Jessie Diana
Published: (2016)

Hepatic PPARα function and lipid metabolic pathways are dysregulated in polymicrobial sepsis
by: Lise Van Wyngene, et al.
Published: (2020-02-01)

AUTOIMMUNE DISEASES AND ATHEROSCLEROSIS - PROBLEMS OF TREATMENT
by: I. V. Shirinskiy, et al.
Published: (2012-05-01)

On homotopically equivalent relations for fiber bundles
by: Suliman Dawood, et al.
Published: (2013-10-01)

Anti-atherogenic effects of fibrates in type 2 diabetes
by: Barter Philip
Published: (2001-09-01)

Supersymmetry and the Hopf fibration
by: Simon Davis
Published: (2012-10-01)

Hypolipemiant Treatment: Making the Right Choice for Osteoporotic Patients
by: Șipoș Remus, et al.
Published: (2013-02-01)

Incidence, predictors and patterns of care of patients with very severe hypertriglyceridemia in Ontario, Canada: a population-based cohort study
by: Amanda J. Berberich, et al.
Published: (2021-09-01)

The Effects of Statin and Fibrate Drugs on Cholesterol Metabolism and Steroid Production in Two Fish Species
by: Al-Habsi, Aziz
Published: (2014)

Cumulative non-HDL-cholesterol burden in patients with hypertriglyceridemia receiving long-term fibrate therapy: Real life data from a lipid clinic cohort
by: Meral Kayıkçıoğlu, et al.
Published: (2020-06-01)

Update on Emerging Treatment Options for Primary Biliary Cholangitis
by: Aguilar MT, et al.
Published: (2020-05-01)

Associação de medicamentos: estatinas e fibratos Combination of drugs: statins and fibrates
by: Hermes Toros Xavier
Published: (2005-10-01)

On retracting properties and covering homotopy theorem for S-maps into Sχ-cofibrations and Sχ-fibrations
by: Amin Saif, et al.
Published: (2016-10-01)

Incidence of pancreatitis, secondary causes, and treatment of patients referred to a specialty lipid clinic with severe hypertriglyceridemia: a retrospective cohort study
by: Francis Gordon A, et al.
Published: (2011-09-01)

First (fuzzy) Hopf map from irreps of SU(2)
by: Fakhri Hossein, et al.
Published: (2013-04-01)

Étude des fibrates en tant qu'agents stimulateurs de la synthèse des cétones, des substrats énergétiques pour le cerveau vieillissant
by: Tremblay-Mercier, Jennifer
Published: (2008)

Zebrafish as a Model for the Study of Lipid-Lowering Drug-Induced Myopathies
by: Magda Dubińska-Magiera, et al.
Published: (2021-05-01)

Combined lipid-lowering and antihypertensive therapy effects on hemostasis in metabolic sydrome patients
by: L. A. Ratnikova, et al.
Published: (2006-04-01)

Lipoprotein Lipase S447X variant associated with VLDL, LDL and HDL diameter clustering in the MetS
by: Tiwari Hemant K, et al.
Published: (2011-08-01)

Cellular cholesterol efflux in heterozygotes for Tangier disease is markedly reduced and correlates with high density lipoprotein cholesterol concentration and particle size
by: Margaret E. Brousseau, et al.
Published: (2000-07-01)